001     178195
005     20240229133802.0
024 7 _ |a 10.1158/2159-8290.CD-21-1094
|2 doi
024 7 _ |a pmid:34921008
|2 pmid
024 7 _ |a 2159-8274
|2 ISSN
024 7 _ |a 2159-8290
|2 ISSN
024 7 _ |a altmetric:119278072
|2 altmetric
037 _ _ |a DKFZ-2021-03193
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 0
|e First author
|u dkfz
245 _ _ |a A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era.
260 _ _ |a Philadelphia, Pa.
|c 2022
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1644586761_6981
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:B062# / 2022 Feb;12(2):331-355
520 _ _ |a Pediatric tumors are uncommon, yet are the leading cause of cancer-related death in childhood. Tumor types, molecular characteristics, and pathogenesis are unique, often originating from a single genetic driver event. The specific diagnostic challenges of childhood tumors led to the development of the first World Health Organization (WHO) Classification of Pediatric Tumors. The classification is rooted in a multilayered approach, incorporating morphology, IHC, and molecular characteristics. The volume is organized according to organ sites and provides a single, state-of-the-art compendium of pediatric tumor types. A special emphasis was placed on 'blastomas,' which variably recapitulate the morphologic maturation of organs from which they originate. SIGNIFICANCE: In this review, we briefly summarize the main features and updates of each chapter of the inaugural WHO Classification of Pediatric Tumors, including its rapid transition from a mostly microscopic into a molecularly driven classification systematically taking recent discoveries in pediatric tumor genomics into account.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Reyes-Múgica, Miguel
|0 0000-0001-5698-3702
|b 1
700 1 _ |a Chan, John K C
|b 2
700 1 _ |a Hasle, Henrik
|0 0000-0003-3976-9231
|b 3
700 1 _ |a Lazar, Alexander J
|0 0000-0002-6395-4499
|b 4
700 1 _ |a Rossi, Sabrina
|b 5
700 1 _ |a Ferrari, Andrea
|0 0000-0002-4724-0517
|b 6
700 1 _ |a Jarzembowski, Jason A
|0 0000-0002-9027-5686
|b 7
700 1 _ |a Pritchard-Jones, Kathy
|0 0000-0002-2384-9475
|b 8
700 1 _ |a Hill, D Ashley
|0 0000-0003-1067-3922
|b 9
700 1 _ |a Jacques, Thomas S
|0 0000-0002-7833-2158
|b 10
700 1 _ |a Wesseling, Pieter
|0 0000-0001-5453-5201
|b 11
700 1 _ |a López Terrada, Dolores H
|0 0000-0002-6584-420X
|b 12
700 1 _ |a von Deimling, Andreas
|0 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
|b 13
|u dkfz
700 1 _ |a Kratz, Christian P
|b 14
700 1 _ |a Cree, Ian A
|0 0000-0001-5007-9456
|b 15
700 1 _ |a Alaggio, Rita
|b 16
773 _ _ |a 10.1158/2159-8290.CD-21-1094
|g p. candisc;2159-8290.CD-21-1094v1
|0 PERI:(DE-600)2607892-2
|n 2
|p 331-355
|t Cancer discovery
|v 12
|y 2022
|x 2159-8274
909 C O |p VDB
|o oai:inrepo02.dkfz.de:178195
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)a8a10626a848d31e70cfd96a133cc144
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-31
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-31
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-15
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER DISCOV : 2021
|d 2022-11-15
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b CANCER DISCOV : 2021
|d 2022-11-15
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l B062 Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)B300-20160331
|k B300
|l KKE Neuropathologie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)B300-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21